First Community Finl (FCMP) 5.3500 $FCMP
First Community Financial Partners, Inc. Reports Net Income Applicable to Common Shareholders of $5.4 Million for the Year Ended December 31, 2014
GlobeNewswire - Wed Jan 21, 4:05PM CST
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community"

, the parent company of First Community Financial Bank (the "Bank"

, today reported that its net income applicable to common shareholders for the three months ended December 31, 2014, was $1.8 million, or $0.11 per diluted share, which was flat when compared with the results of $1.9 million, or $0.11 per diluted share, for the three months ended September 30, 2014. Net income applicable to common shareholders for the year ended December 31, 2014, was $5.4 million, or $0.32 per diluted share, compared with $20.6 million, or $1.29 per diluted share, for the year ended December 31, 2013. The results for 2013 included an income tax benefit of $14.6 million primarily related to the reversal of a previously established deferred tax valuation allowance and $4.9 million related to gains on redemption of preferred stock. Income before income taxes was $8.6 million for the year ended December 31, 2014, as compared to $2.1 million for the year ended December 31, 2013.
First Community Financial Partners, Inc. Completes Repurchase of $6.3 Million of Preferred Stock
GlobeNewswire - Tue Dec 09, 3:30PM CST
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community"

, repurchased all of its remaining outstanding shares of Fixed Rate Cumulative Perpetual Preferred Stock, Series B (the "Series B Preferred Stock"

, and Fixed Rate Cumulative Perpetual Preferred Stock, Series C (the "Series C Preferred Stock"

, that were originally issued to the U.S. Department of the Treasury under the Troubled Asset Relief Program Capital Purchase Program ("TARP"

. 5,176 shares of Series B Preferred Stock and 1,100 shares of Series C Preferred Stock, with a liquidation preference of $1,000 per share, were repurchased from certain third-party investors at an aggregate purchase price of $6.3 million. The proceeds from First Community's 7.0% subordinated debt raise that closed on October 31, 2014 were used to fund the repurchase of the preferred stock. With the Series B Preferred Stock dividend rate increasing from 5% to 9% in 2015, the repurchase of the preferred stock will result in an estimated annual savings of $301,000, due to the elimination of payment of dividends on the repurchased shares. "The retirement of the preferred stock eliminates the remnants of TARP," said Roy C. Thygesen, CEO. "We are pleased to put closure to this chapter and to continue enhancing our returns to common shareholders."
First Community Financial Partners, Inc. Reports Net Income of $3.5 million, or $0.21 per Diluted Share, for the Nine Months Ended September 30, 2014
GlobeNewswire - Tue Oct 21, 4:08PM CDT
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community"

, the parent company of First Community Financial Bank (the "Bank"

, today reported that its net income applicable to common shareholders for the three months ended September 30, 2014 rose to $1.9 million, or $0.11 per diluted share, compared with $1.3 million, or $0.08 per diluted share, for the three months ended June 30, 2014.
First Community Financial Partners, Inc. Reports a 57.24% Reduction in Nonperforming Assets for the Twelve Months Ended June 30, 2014
GlobeNewswire - Tue Jul 22, 3:59PM CDT
First Community Financial Partners, Inc. (OTCQB:FCMP) ("First Community"

, the parent company of First Community Financial Bank (the "Bank"

, today reported that its net income applicable to common shareholders for the three months ended June 30, 2014 was $1.3 million, or $0.08 per diluted share, compared with $567,000, or $0.03 per diluted share, for the three months ended June 30, 2013.
NPS Pharmaceuticals Joins Participants from around the World in Observing Rare Disease Day
Business Wire - Fri Feb 28, 7:30AM CST
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) a biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today joins patient organizations, healthcare professionals, researchers, public health authorities and the biopharmaceutical industry in recognizing Rare Disease Day. As a "Friend of Rare Disease Day," NPS strives to increase recognition of rare diseases and educate the public about their global impact on society. Internationally, the observance is led by the European Organisation for Rare Diseases (EURORDIS) and in the US by the National Organization for Rare Disorders (NORD).
NPSP: 45.88 (+0.03)